Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

What a pity that a Republican administration needs to be reminded that this misguided policy won’t make America healthy or great.

The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase ...

Regeneron bids for 23andMe at a discounted price of $256 million. The testing firm was once valued at $3.5 billion.

Laminin 521 (Cat. No. GMP-LA5H24) successfully maintained rapid expansion of human iPSCs, enabling cell passaging after just ...

For decades, scientists and surgeons around the world have been trying to solve the organ donor crisis. The answer could be ...

Artificial intelligence is revolutionizing the way we care for animals. Once limited to reactive treatments at vet clinics, animal healthcare is evolving into a proactive, data-driven field where AI ...

Three-dimensional printing is transforming medical care, letting the health care field shift from mass-produced solutions to ...

Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

Aksh Ladegaonkar , a sophomore at International Baccalaureate at Bartow High School, earned second place in the Dr. Nelson ...

Is Maggie leaving FBI? Discover the truth behind Missy Peregrym’s absence, what sparked the exit rumours, and whether Maggie ...

The pharmaceutical industry's patience is wearing thin with the Trump administration's pressure. But the administration doesn ...